Pharmaceuticals
-
DNA clue to child brain tumour success
DNA testing might help identify children with brain tumours that will respond to adult medications, British researchers have reported. Read more
-
New hope for common cold treatment
British researchers say they may be close to an effective treatment for the common cold. Read more
-
PARP mutation latest personalisation possibility
British researchers have found a mutation that prevents PARP inhibitors from working, it has been announced. Read more
-
Fish oil part of osteoarthritis self-management
Improved diet and weight loss are crucial to self-management of osteoarthritis, according to a new analysis. Read more
-
Disappointing breast cancer drug may accelerate cancer cell growth
A drug developed to treat breast cancer can accelerate cancer cell growth in some situations, a new study has revealed. Read more
-
MDMA may benefit PTSD
The banned drug MDMA could be a useful addition to the treatment for post-traumatic stress disorder, researchers say today. Read more
-
Carboplatin effective when BRCA gene present
Women with advanced ‘triple-negative’ breast cancer and BRCA gene mutations respond better to the chemotherapy drug carboplatin than standard treatment, according to the findings of a major clinical trial published last night. Read more
-
The best treatments for post-partum haemorrhage
Oxytocin should not be the drug of choice for treating post-partum haemorrhage, according to a global analysis led by a British researcher. Read more
-
Women reject preventative tamoxifen
Most women with family history of breast cancer will refuse to take tamoxifen as a prophylactic, researchers warn today. Read more
-
Europe challenged to tackle vaccine uptake
European countries need to tackle the problem of families that reject the use of vaccines – and the need for action is immediate in the light of recent measles outbreaks, senior doctors have warned. Read more
